SCHEMBL9520685

SCHEMBL9520685

CC(C#N)CCCCOc1cc(-c2ccccc2)c2ccccc2n1

nearest known ligand 0.69

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LTB4R Q15722 20/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8987154 0.83 LTB4R (0.66) LTB4R
SCHEMBL8987295 0.79 LTB4R (0.69) LTB4R
SCHEMBL8986991 0.78 LTB4R (0.80) LTB4R
SCHEMBL8987079 0.76 LTB4R (0.69) LTB4R
SCHEMBL8987479 0.75 LTB4R (0.86) LTB4R
SCHEMBL8987078 0.74 LTB4R (0.84) LTB4R
SCHEMBL8987249 0.73 LTB4R (1.00) LTB4R
SCHEMBL8987194 0.73 LTB4R (1.00) LTB4R
SCHEMBL8987184 0.73 LTB4R (1.00) LTB4R
SCHEMBL8987185 0.73 LTB4R (1.00) LTB4R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0540604-A1 SUBSTITUTED BICYCLIC BIS-ARYL COMPOUNDS EXHIBITING SELECTIVE LEUKOTRIENE B 4? ANTAGONIST ACTIVITY, THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS Aventis Pharma S.A. (FR) 1993-05-12 EP disclosed
WO-1992001675-A2 SUBSTITUTED BICYCLIC BIS-ARYL COMPOUNDS EXHIBITING SELECTIVE LEUKOTRIENE B4 ANTAGONIST ACTIVITY, THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS RHONE-POULENC RORER S.A. (FR) 1992-02-06 WO disclosed